| Literature DB >> 27076135 |
Maria Malm1, Kirsi Tamminen1, Vesna Blazevic2.
Abstract
Norovirus (NoV)-specific serum antibodies bind to NoV-derived virus-like particles (VLPs) and block the binding of VLPs to the host cell attachment factors/receptors, histo-blood group antigens (HBGAs). Blocking antibodies in human sera have been associated with a protection from NoV infection and disease. Studies of experimental NoV VLP-based vaccines measure blocking antibodies in animal sera instead of a traditional virus neutralization assay. This chapter describes the methodology for analyzing blocking antibodies from NoV GII.4 VLP-immunized mouse sera. Protocol for obtaining mouse NoV GII.4-specific immune sera is described, followed by the detailed protocol for blocking assay using synthetic HBGAs.Entities:
Keywords: Antibody; Blocking assay; HBGAs; Norovirus; VLPs; Vaccine
Mesh:
Substances:
Year: 2016 PMID: 27076135 DOI: 10.1007/978-1-4939-3387-7_13
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745